Title of article :
Interleukin 9 production in the lungs of infants with severe respiratory syncytial virus bronchiolitis
Author/Authors :
Paul S McNamara، نويسنده , , Brian F. Flanagan، نويسنده , , Lisa M Baldwin، نويسنده , , Paul Newland، نويسنده , , C Anthony Hart، نويسنده , , Rosalind L Smyth، نويسنده ,
Issue Information :
روزنامه با شماره پیاپی سال 2004
Pages :
7
From page :
1031
To page :
1037
Abstract :
Respiratory syncytial virus (RSV) bronchiolitis is the most prevalent acute wheezing disorder in infants and is associated with recurrent wheeze and asthma in childhood. Interleukin 9, a type 2 cytokine has been proposed as a key cytokine in susceptibility to asthma. We aimed to investigate whether interleukin 9 was produced in the lungs of infants with severe RSV disease and if found, from which cells it originated. Methods We did 150 non-bronchoscopic bronchoalveolar lavages during the course of ventilation in 24 term infants and 21 preterm infants ventilated for RSV bronchiolitis. We also did 10 bronchoalveolar lavages on the day of intubation in 10 control infants ventilated for non-respiratory causes. We measured pulmonary interleukin 9 mRNA and protein in samples from all groups. We used immunostaining to identify the cells that produce interleukin 9. Findings Interleukin 9 mRNA expression, which persisted over the course of ventilation, was noted in all infants with bronchiolitis. Three of the control group also showed interleukin 9 mRNA expression. Median interleukin 9 protein concentration on day 1 (1·9 μg/L [range 0·1–36·2]) was significantly greater in term infants with bronchiolitis than either preterm infants (0·4 μg/L [0·1–2·9]; p<0·05) or the control group (0·7 μg/L [0·4–2·5]; p<0·05). There was a trend for interleukin 9 protein concentrations in term, but not preterm infants to decrease over time. Immunostained cell smears showed that most interleukin 9 expression in bronchoalveolar lavage was by neutrophils. Interpretation In term infants with RSV bronchiolitis, we noted large amounts of interleukin 9 mRNA and interleukin 9 protein. Neutrophils seem to be the main source of this type 2 cytokine. Interleukin 9 production by neutrophils may contribute to the pathogenesis of RSV disease. These findings may be relevant to other disease processes in the lung where neutrophils are the predominant inflammatory cell type.
Journal title :
The Lancet
Serial Year :
2004
Journal title :
The Lancet
Record number :
560587
Link To Document :
بازگشت